Celgene Corporation (CELG)

BiotechnologyHealthcare

108.240.11(0.10%)

26/01/2020 19:13:54


52 Week L/H
83.12
110.41

CELG Stock Price Chart


Fundamental ratios

Price-to-Earnings Ratio (TTM)
13.5
Price-to-Earnings Ratio (5 year avg)
46.5
Enterprise-value-to-EBITDA ratio
10.83
Price-to-book ratio
6.45
Price/Earnings-to-Growth Ratio
0.05
EV/Invested Capital
86,873 Million

Profitability ratios

Return on Invested Capital
22.2
Return on Invested Capital average (5y)
14.52
Return on Equity
2.25
Return on Equity average (5y)
39.26
Return on Assets
0.49
Return on Assets average (5y)
9.14

Growth rates

Revenue growth
Revenue growth 5y CAGR
14.78
EBITDA growth
0.0
EBITDA 5y CAGR
16.63
Net Income growth
0.0
Net Income 5y CAGR

Stock Margins

Gross Margin
96.3
Gross Margin Average (5y)
96.3
EBITDA Margin
47.6
EBITDA Margin Average (5y)
35.73
Net Margin
127.9
Net Margin average (5y)
21.8

Risk and leverage

Max. Drawdown 5yNA
Return over Max Drawdown (5y)-0.19%
Max. Drawdown since GR-59.59%
Return over Max D. Since GR
Debt to Equity
1.64
Interest Coverage Ratio
9.7

Dividends and its sustainability

Dividend Yield
NA
Dividend per share
NA
DPS 5y CAGR
NA
Dividend payout ratio
0.0
Dividend to FCF
NA
Payout Ratio
0.0

Basic Information

Earnings per Share (EPS)
8.33
EPS Estimate Currrent Qtr
2.88
Book Value Per Share
16.98
Market Cap
77,036 Million
PE Ratio
13.5
Enterprise Value
86,873 Million
Invested Capital
114,093 Million

Stock Yield

Stock Return 7 Days
NA
Stock Return 15 Days
NA
Stock Return 30 Days
NA
Stock Return 3 Months2.40%
Stock Return One Year24.04%
Stock Return 3 Years-2.95%

Note: Calculations based on previous day's adjusted closing prices

Stock Technical Analysis

Relative Strengh Index (14)
60.87
Momentum (14)
0.29
Simple Moving Average (14)
109.02
Exponential Moving Average (14)
108.45
Average True Range
16.58

Note: Calculations based on previous day's adjusted closing prices